Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -197,614 | -143,589 | -97,329 | -38,992 | -36,240 |
| Depreciation Amortization | 2,972 | 1,904 | 1,312 | 1,086 | 4,710 |
| Accounts payable and accrued liabilities | 1,033 | 466 | 1,303 | 1,965 | -526 |
| Other Working Capital | 2,922 | 6,357 | 504 | -556 | 62,891 |
| Other Operating Activity | 39,111 | 30,929 | 20,712 | 6,174 | 19,281 |
| Operating Cash Flow | $-151,576 | $-103,933 | $-73,498 | $-30,323 | $50,116 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,919 | -15,146 | -12,299 | -2,028 | -3,393 |
| Purchase Of Investment | -369,696 | -219,139 | -144,029 | -109,810 | -557,930 |
| Sale Of Investment | 535,327 | 339,612 | 212,162 | 103,791 | 273,901 |
| Investing Cash Flow | $147,712 | $105,327 | $55,834 | $-8,047 | $-287,422 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,190 | 4,156 | 3,477 | 908 | 98,405 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,386 |
| Financing Cash Flow | $6,190 | $4,156 | $3,477 | $908 | $97,019 |
| Beginning Cash Position | 78,623 | 78,623 | 78,623 | 78,623 | 218,910 |
| End Cash Position | 80,949 | 84,173 | 64,436 | 41,161 | 78,623 |
| Net Cash Flow | $2,326 | $5,550 | $-14,187 | $-37,462 | $-140,287 |
| Free Cash Flow | |||||
| Operating Cash Flow | -151,576 | -103,933 | -73,498 | -30,323 | 50,116 |
| Capital Expenditure | -17,919 | -15,146 | -12,299 | -2,028 | -3,393 |
| Free Cash Flow | -169,495 | -119,079 | -85,797 | -32,351 | 46,723 |